Difference between revisions of "Team:TAS Taipei"

Line 286: Line 286:
 
         <div u="slides" style="cursor: move; position: absolute; left: 0px; top: 0px; width: 1080px; height: 600px;
 
         <div u="slides" style="cursor: move; position: absolute; left: 0px; top: 0px; width: 1080px; height: 600px;
 
             overflow: hidden;">
 
             overflow: hidden;">
             <div><div u="image" style = "lightgrey;text-align:center"><image style = "width:1080px" src="https://static.igem.org/mediawiki/2016/5/58/T--TAS_Taipei--TeamPhoto.jpg"/></div>
+
              
                <div u="caption" t="T" style="box-shadow: 0 0 10px 0;background-color:purple;padding:10px;position: absolute; top: 30px; left: 120px;border-style:solid;border-color:gold;border-width:10px">
+
                    <p style = "color:white;font-size:30px;">
+
                    <b>TAS Taipei: 2016 iGEM Team</b>
+
                    </p>
+
                    <p style = "color:white;font-size:30px;">
+
                   
+
                    </p>
+
                   
+
                </div>
+
                </div>
+
 
             <div><img u="image" src="https://static.igem.org/mediawiki/2016/c/cb/T--TAS_Taipei--Counteract_Homepage_Banner.jpg"/></div>
 
             <div><img u="image" src="https://static.igem.org/mediawiki/2016/c/cb/T--TAS_Taipei--Counteract_Homepage_Banner.jpg"/></div>
 
             <div><div u="image" id="image1ani" style = "lightgrey;text-align:center"><image src="https://static.igem.org/mediawiki/2016/4/41/T--TAS_Taipei--PurificationAnimation.gif"/></div>
 
             <div><div u="image" id="image1ani" style = "lightgrey;text-align:center"><image src="https://static.igem.org/mediawiki/2016/4/41/T--TAS_Taipei--PurificationAnimation.gif"/></div>
Line 319: Line 309:
 
             </div>
 
             </div>
 
             <div><div u="image" style = "text-align:center"><image src="https://static.igem.org/mediawiki/2015/6/6c/Tas_frontpage_2.jpeg"/></div>
 
             <div><div u="image" style = "text-align:center"><image src="https://static.igem.org/mediawiki/2015/6/6c/Tas_frontpage_2.jpeg"/></div>
             <div u="caption" t="L" style="box-shadow: 0 0 10px 0;background-color:orange;padding:10px;position: absolute; top: 330px; left: 20px;">
+
             <div><div u="image" style = "lightgrey;text-align:center"><image style = "width:1080px" src="https://static.igem.org/mediawiki/2016/5/58/T--TAS_Taipei--TeamPhoto.jpg"/></div>
                     <p style = "width:350px; color:white;font-size:22px;">
+
                <div u="caption" t="T" style="box-shadow: 0 0 10px 0;background-color:purple;padding:10px;position: absolute; top: 30px; left: 120px;border-style:solid;border-color:gold;border-width:10px">
                     "I appreciate the interdisciplinary aspect of iGEM. Aside from its strong focus on science which I enjoyed, iGEM also incorporates human, design, and technological elements."
+
                     <p style = "color:white;font-size:30px;">
 +
                     <b>TAS Taipei: 2016 iGEM Team</b>
 
                     </p>
 
                     </p>
                     <p style = "color:white;font-size: 16px">
+
                     <p style = "color:white;font-size:30px;">
                     - Joseph Chuang
+
                      
 
                     </p>
 
                     </p>
 +
                   
 +
                </div>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>

Revision as of 15:29, 19 October 2016

TAS Taipei iGEM Wiki





PROTOTYPE

Package purified proteins into nanoparticles

DELIVERY INTO THE EYE

Nanoparticles allow passage through the cornea

TAS Taipei: 2016 iGEM Team

Image Slider


ABSTRACT


Cataracts, the clouding of the lens, cause half of the world's blindness. Most cataracts are age-related and arise when crystallin proteins in the lens become oxidized and aggregate over time. Surgery is currently the only recognized treatment to effectively cure cataracts, but this method is expensive and invasive. Therefore, we formulated a natural and non-invasive alternative. In the eye, a natural antioxidant glutathione (GSH)—produced by the enzyme glutathione reductase (GSR)—exists to combat oxidation, but GSH levels decrease with age. Studies have also suggested that another enzyme—25-hydroxylase (CH25H)—can convert cholesterol in the eye into 25-hydroxycholesterol (25HC), which reverses crystallin aggregation. We expressed and purified GSR and CH25H for the prevention and treatment of cataracts, respectively. To deliver these proteins through the cornea and into the lens, we engineered biodegradable chitosan nanoparticles, thus creating a natural and non-invasive alternative to surgery.




Prevention

GSR Eyedrop

Treatment

25HC Eyedrop

LOCS: 0      


Eyedrops